Nuwellis currently has an average rating of "Buy" from just one analyst. It's worth asking whether this recommendation is rooted in technical analysis. Typically, technical analysis examines past price movements, chart patterns, and momentum to gauge market sentiment and predict future trends. In the case of Nuwellis, such analysis would focus on how investors perceive its potential based on historical price behavior. To get a clearer picture, we should explore some key technical indicators—like support and resistance levels, volume trends, and moving averages—that might shed light on the stock’s current momentum and possible future direction. Understanding these aspects can help determine whether the "Buy" rating reflects genuine confidence or simply a snapshot of recent trading activity.
Primary Points
Nuwellis (NASDAQ: NUWE) is currently showing a mean deviation of 8.67 and a period momentum indicator of -0.96, suggesting increased volatility and downward pressure. The stock's last price of
14.80 remains below its high of
16.50, and with a beta of 0.464, it tends to move less than the overall market, but recent risk metrics like the maximum drawdown of
132.35 highlight potential downside risks. While the trading volume of
173.2K indicates some investor interest, the negative net income of
-11.2M and a risk-adjusted performance close to zero suggest caution whether the stock is poised for a rebound or further decline in August.
Using predictive
technical analysis, we can analyze different prices and returns patterns and
diagnose historical swings to determine the real value of Nuwellis. In general, sophisticated investors focus on analyzing Nuwellis stock price patterns and their correlations with different microeconomic environment and drivers. They apply predictive analytics to build Nuwellis's daily price indicators and compare them against related drivers such as
momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional
technical analysis and
fundamental analysis, we attempt to find the most accurate representation of Nuwellis's intrinsic value. In addition to deriving basic predictive indicators for Nuwellis, many experienced traders also check how macroeconomic factors affect Nuwellis price patterns. Please read more on our
technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed
many market ups and downs, anticipate that the market will even out over time. This tendency of Nuwellis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
How does Nuwellis Stands against Peers?
Analyzing Nuwellis competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Nuwellis across multiple sectors and
thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be. Check out
Nuwellis Competition DetailsNuwellis Gross Profit
Nuwellis Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Nuwellis previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Nuwellis Gross Profit growth over the last 10 years. Please check Nuwellis'
gross profit and other
fundamental indicators for more details.
Closer look at Nuwellis Mean Deviation
Nuwellis has current Mean Deviation of 8.67. The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns.
Mean Deviation is the average of the absolute values of the differences between price distribution numbers and their mean. Mean deviation of equity instrument with a lot of historical data is a biased estimator because the time horizon used in calculation will always be much smaller than the entire price history of the equity.
The mean deviation is typically used as a measure of dispersion for small investment horizon, otherwise standard deviation is a better measure of dispersion.
Mean Deviation | = | SUM(RET DEV)N |
| = | 8.67 |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of Nuwellis |
| N | = | Number of calculation points for selected time horizon |
Let's now compare Nuwellis Mean Deviation to its closest peers:
| NUWE | 8.673180915518826 |
| SINT | 4.1 |
| RSLS | 7.71 |
| BBLG | 4.91 |
| TIVC | 4.8 |
A rising tide lifts all boats, but Nuwellis (NASDAQ: NUWE) appears to be struggling to catch that wave right now. The stock's 50-day moving average of 23.82 remains well above the current price of around 15.20, indicating recent downward momentum. Despite a solid current ratio of 4.55X and cash holdings of 12.05M, the company faces significant challenges with net income at a loss of 11.2M and a risk-adjusted performance close to zero, suggesting limited upside in the near term. With a beta of 0.46 and a relatively low short interest at 0.58%, the stock isn't heavily shorted, but the technicals point to continued volatility rather than a clear rebound. Investors should watch for a potential bottoming pattern before considering any positions, as the current momentum signals caution..
Will Nuwellis continue to go ballistic?
Nuwellis's current Value at Risk (VaR) is -14.84, indicating a higher potential for downside movement. While some traders might see this as a warning, it also hints at possible opportunities if the company can stabilize or improve its outlook. The key question is whether Nuwellis will rebound or face further volatility. Investors should monitor how the company manages its risks and whether it can regain momentum after recent declines. As of July 19th, Nuwellis shows a Risk-Adjusted Performance of 0.0098, with a downside deviation of 11.41 and a mean deviation of 8.67. Technical indicators like Jensen Alpha and downside variance suggest the stock may be somewhat fairly valued at around $14.80 per share.
With a Jensen Alpha of -0.22, it’s wise to review recent market activity to assess if the company can sustain its current level.Investing in Nuwellis presents a mix of potential and caution. With an analyst consensus leaning toward a "Buy" and a highest estimated target price of $14.43, there’s a sense of optimism about its future prospects. The possible upside of around 35.37% suggests that the stock could offer meaningful gains if the company meets expectations. However, the downside risk isn’t negligible, with a possible drop to just $0.15, so careful consideration of the company’s fundamentals and market conditions is essential. Currently valued at approximately
14.8M, Nuwellis might appeal to investors willing to accept some volatility for the chance of upside, especially given the valuation’s hype value and the forecasted fair value near $13. Overall, it’s a name worth watching, but due diligence remains key before jumping in..
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Nuwellis. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com